Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 12/11/2019
SIETES contiene 92833 citas

 1 a 20 de 353 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Khan R, Nugent CM, Scaffidi MA, Gimpaya N, Grover SC. Association of biologic prescribing for inflammatory bowel disease with industry payments to physicians. JAMA Intern Med 2019;179:8 de julio. [Ref.ID 103170]
3. Cita con resumen
Booth CM, Detsky AS. From the $80 hamburger to managing conflicts of interest with the pharmaceutical industry. BMJ 2019;365:3 de mayo. [Ref.ID 103106]
4. Cita con resumen
Mir de Francia R. Los fabricantes de opioides fijan a España como nuevo mercado. 2018:1. [Ref.ID 102452]
5. Cita con resumen
Edwards IR. A new Erice report considering the safety of medicines in the 21st Century. Drug Saf 2017;40:845-9. [Ref.ID 102074]
6. Cita con resumen
Tsai W-C, Wu H-Y, Peng Y-S, Yang J-Y, Chen HY, Chiu Y-L, Hsu S-P, Ko M-J, Pai M-F, Tu Y-K, Hung K-Y, Chien K-L. Association of a communication training program with use of antipsychotics in nursing homes. JAMA Intern Med 2017;177:846-53. [Ref.ID 101620]
7.Enlace a cita original Cita con resumen
Robert L, Diego L, Llop R, Juárez JC. Incorporar los recursos de referencia sobre medicamentos y farmacoterapia a nuestro entorno personal de aprendizaje. Terapéutica en APS 2017;24:38-47. [Ref.ID 101350]
9. Cita con resumen
Agrawal S, Brown D. The physician payments Sunshine Act — Two years of the Open Payments program. N Engl J Med 2016;374:906-9. [Ref.ID 100205]
10. Cita con resumen
Watson R. Council of Europe tackles drug industry’s “less noble” side. BMJ 2015;351:h5474. [Ref.ID 99593]
11. Cita con resumen
McCarthy M. Industry paid $6.5bn to US physicians and hospitals in 2014. BMJ 2015;351:h3697. [Ref.ID 99244]
12. Cita con resumen
Anónimo. Drug and medical-device makers paid $6.49 billion to physicians, hospitals in 2014. DIA Daily 2015:1 de julio. [Ref.ID 99224]
13. Cita con resumen
Ornstein C, Jones RG. Vying for market share, companies heavily promote ‘me too’ drugs. ProPublica 2015:7 de enero. [Ref.ID 98702]
15. Cita con resumen
Piening S, de Graeff PA, Straus SMJM, Haaijer-Ruskamp FM, Mol PGM. The additional value of and e-mail to inform healthcare professionals of a drug safety issue: a randomized controlled trial in the Netherlands. Drug Saf 2013;36:723-31. [Ref.ID 96212]
16. Cita con resumen
Iacobucci G. Healthcare professionals recevied &40m from drug companies last year. BMJ 2013;346:6. [Ref.ID 95437]
17. Cita con resumen
Anónimo. Disclosure of pharma sponsorship made compulsory in Portugal. BMJ 2013;346:2. [Ref.ID 95369]
18.Enlace a cita original
Likic R, White C, Cinti S, Purkiss J, Fantone J, Chapman C, Bielen L, Francetic I, Engleberg C. Online learning applied to a course on rational therapeutics: an international comparison between final year students of two medical schools. Br J Clin Pharmacol 2013;75:373-80. [Ref.ID 94853]
19.Enlace a cita original
Maxwell S, Mucklow J. e-Learning initiatives to support prescribing. Br J Clin Pharmacol 2012;74:621-31. [Ref.ID 93877]
Seleccionar todas
 1 a 20 de 353 siguiente >>